Professional Overview
Bariş Aynur is a dedicated Sales Representative with a strong background in the pharmaceutical industry, currently contributing to Bilim İlaç in Turkey. His expertise lies in sales representation, with a focus on the pharmaceutical sector.
Experience Summary
Current Role
As a Sales Representative at Bilim İlaç since March 2024, Bariş Aynur is responsible for driving sales growth, managing client relationships, and promoting pharmaceutical products. Although specific achievements are not detailed, his role significantly impacts the industry by ensuring the delivery of essential medications to the market.
Career Progression
Notable previous roles include his position as a Representative at TK İLAÇ from 2019 to 2022. This experience likely contributed to his career growth, enhancing his sales and representation skills within the pharmaceutical industry.
Academic Background
Bariş Aynur holds a Lisans Derecesi in Public Administration from Gaziosmanpaşa Üniversitesi (Gaziosmanpasa University), which he completed between 2013 and 2016. This educational background provides a foundation in administrative principles that can be applied to his professional roles.
Areas of Expertise
While specific areas of expertise are not detailed, Bariş Aynur's experience suggests proficiency in sales, customer relationship management, and potentially in pharmaceutical product knowledge.
Professional Impact
Although specific projects or initiatives are not mentioned, Bariş Aynur's contributions to the pharmaceutical industry through his sales roles are crucial for the distribution and promotion of healthcare products.
Conclusion
Bariş Aynur's professional trajectory indicates a focused career in sales within the pharmaceutical industry. Currently, his role at Bilim İlaç showcases his commitment to this field. With his educational background in Public Administration and his experience in sales representation, Bariş Aynur brings value through his ability to manage sales processes effectively and contribute to the pharmaceutical industry's growth.
